We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$30.7B
AUM Growth
-$5.52B
Cap. Flow
-$219M
Cap. Flow %
-0.71%
Top 10 Hldgs %
16.4%
Holding
1,624
New
85
Increased
603
Reduced
480
Closed
83

Top Buys

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$126M
2
LIN icon
Linde
LIN
+$121M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$108M
4
CI icon
Cigna
CI
+$58.9M
5
CUK
Carnival PLC
CUK
+$43M

Top Sells

Rank Stock Value
1
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$140M
2
ESRX
Express Scripts Holding Company
ESRX
+$103M
3
AET
Aetna Inc
AET
+$99.9M
4
DELL icon
Dell
DELL
+$88.2M
5
COL
Rockwell Collins
COL
+$58M

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Financials 15.79%
3 Healthcare 13.93%
4 Consumer Discretionary 10.06%
5 Industrials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
1451
Voyager Therapeutics
VYGR
$197M
$211K ﹤0.01%
22,500
– –
CASI
1452
DELISTED
CASI Pharmaceuticals
CASI
$209K ﹤0.01%
5,200
– –
CBMG
1453
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$207K ﹤0.01%
12,100
– –
LJPC
1454
DELISTED
La Jolla Pharmaceutical Company
LJPC
$207K ﹤0.01%
22,000
+200
+0.9% +$3.01K
ACRS icon
1455
Aclaris Therapeutics
ACRS
$860M
$205K ﹤0.01%
27,800
– –
RUBY
1456
DELISTED
Rubius Therapeutics, Inc
RUBY
$203K ﹤0.01%
12,600
– –
ADMS
1457
DELISTED
Adamas Pharmaceuticals
ADMS
$194K ﹤0.01%
22,700
+100
+0.4% +$1.3K
CPRX
1458
DELISTED
Catalyst Pharmaceutical
CPRX
$190K ﹤0.01%
99,000
+45,000
+83% +$129K
ADVM
1459
DELISTED
Adverum Biotechnologies
ADVM
$179K ﹤0.01%
5,690
– –
HCR
1460
DELISTED
Hi-Crush Inc. Common Stock
HCR
$179K ﹤0.01%
50,000
– –
GTX icon
1461
Garrett Motion
GTX
$5.47B
$177K ﹤0.01%
+14,334
New +$195K
GERN icon
1462
Geron
GERN
$1.01B
$174K ﹤0.01%
174,000
+8,100
+5% +$12.3K
AVEO
1463
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$172K ﹤0.01%
10,720
+120
+1% +$2.64K
ATHX
1464
DELISTED
Athersys, Inc. Common Stock
ATHX
$168K ﹤0.01%
4,660
+1,660
+55% +$79.2K
PRTK
1465
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$167K ﹤0.01%
32,500
+16,500
+103% +$125K
TYME
1466
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$165K ﹤0.01%
+44,600
New +$125K
PPC icon
1467
Pilgrim's Pride
PPC
$6.4B
$159K ﹤0.01%
10,240
– –
QIWI
1468
DELISTED
QIWI PLC
QIWI
$158K ﹤0.01%
11,145
-517
-4% -$6.97K
LRMR icon
1469
Larimar Therapeutics
LRMR
$454M
$157K ﹤0.01%
2,642
+667
+34% +$65.8K
MNKD icon
1470
MannKind Corp
MNKD
$1.24B
$155K ﹤0.01%
146,600
– –
FBRX icon
1471
Forte Biosciences
FBRX
$1.57B
$152K ﹤0.01%
+49
New +$211K
FSTX
1472
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$151K ﹤0.01%
+3,625
New +$163K
SYRS
1473
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$148K ﹤0.01%
2,660
+90
+4% +$6.84K
LCI
1474
DELISTED
Lannett Company, Inc.
LCI
$148K ﹤0.01%
7,475
+2,225
+42% +$42.3K
ALDX icon
1475
Aldeyra Therapeutics
ALDX
$91.7M
$146K ﹤0.01%
17,600
– –
57 58
59
60 61

Similar funds

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State of Wisconsin Investment Board's Q4 2018 Portfolio in Review

As of Q4 2018, State of Wisconsin Investment Board held 1,624 positions worth $30.7B, down 15% from $36.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board's Q4 2018 filing shows 85 new, 603 increased, 480 reduced and 83 closed positions. Its largest new stake was Linde: 763,981 shares worth $120M. The largest sale was Twenty-First Century Fox, Inc. Class B, an estimated $140M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q4 2018 buy was Linde: 763,981 shares worth $120M.
  • State of Wisconsin Investment Board added most to DocuSign in Q4 2018, an estimated $126M increase.
  • State of Wisconsin Investment Board's biggest Q4 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $140M.
  • State of Wisconsin Investment Board fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $103M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $30.7B portfolio in Q4 2018.
  • State of Wisconsin Investment Board opened 85 new positions and closed 83 in Q4 2018.
  • State of Wisconsin Investment Board's portfolio value fell 15% quarter-over-quarter to $30.7B.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2018, filed 11 Feb 2019.